Offstream
news

---

Changes

1. Swissmedic grants authorization of the Moderna vaccine for used in Switzerland, making it the second vaccine to be approved in the country.
   2021-01-12 17:05:22 (First version)
2. Swissmedic grants authorization of the Moderna vaccine for use in Switzerland, making it the second COVID-19 vaccine to be approved in the country.
   2021-01-13 01:05:29 (Update)
3. Swissmedic grants authorization for use of the Moderna vaccine in Switzerland, making it the second COVID-19 vaccine to be approved in the country.
   (Current version)

---

Related

Moderna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant.
2022-08-22

Moderna requests emergency use authorization for its COVID-19 vaccine in babies, toddlers, and young children.
2022-04-28

The Indonesian Drug and Food Control Agency issues an emergency use authorization of five COVID-19 vaccines as booster dose, namely Pfizer–BioNTech, AstraZeneca, CoronaVac, and Zifivax's ZF2001 for one dose, and half dose of the Moderna COVID-19 vaccine.
2022-01-10

The Czech government announces that the country will begin offering a booster dose of the COVID-19 vaccine from September 20 to all people who previously have been vaccinated at least eight months ago using either Pfizer or Moderna vaccines.
2021-08-30

The Medicines and Healthcare Products Regulatory Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the second vaccine to be approved for use in children after the Pfizer-BioNTech vaccine.
2021-08-17

Chancellor Angela Merkel receives her second dose of the COVID-19 vaccine. However, Merkel received the Moderna vaccine for her second dose rather than the AstraZeneca vaccine.
2021-06-22

Italy suspends the use of the Oxford-AstraZeneca vaccine in people under the age of 60 nationwide following the death of an 18-year-old girl yesterday and reports of other young people who have been hospitalized in critical condition after receiving their first dose of the vaccine. The Moderna and Pfizer vaccines will be used for the vaccination of people under the age of 60, including for people who already received a first dose of the AstraZeneca vaccine.
2021-06-11

The Japanese government officially approves the use of the Moderna and Oxford–AstraZeneca COVID-19 vaccines for people aged 18 and older. It comes after the Health Ministry panel recommended the approval of both vaccines.
2021-05-21

The United States begins shipping the COVID-19 vaccine made by Moderna.
2020-12-20

Swissmedic approves the authorization of the Pfizer-BioNTech vaccine for use in Switzerland.
2020-12-19